Back

Novel admission hyperglycaemia markers as predictors of poor outcomes following percutaneous coronary interventions: a dose-response meta-analysis

29 August 2025 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Biomarkers in acute coronary syndromes (2) Biomarkers ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mr Paulus Siahaan

Airlangga University, Surabaya (Indonesia)

7 More presentations in this session

Presentation thumbnail
Clonal Hematopoiesis of Indeterminate Potential (CHIP) mutations in patients with coronary artery disease
Doctor N. Senguttuvan (Chennai, IN)
Abstract Slides Video
Presentation thumbnail
Albumin-based inflammation scores with integrated thrombotic markers outperform conventional predictors for mortality in acute coronary syndrome and atrial fibrillation
Doctor H. Liang (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
The clinical significance of misleading troponin elevations: is macrotroponin a culprit for unnecessary invasive coronary angiography?
Mr A. Holst Kronborg (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Diagnostic and prognostic utility of neutrophil-to-lymphocyte ratio as a biomarker in patients with acute chest pain
Mr B. Okamura (Basel, CH)
Abstract Slides Video
Presentation thumbnail
High frequency of macrotroponin i in the upper troponin range of a healthy reference population but no variation by age or sex
Mrs N. Strandkjaer (Copenhagen, DK)
Abstract Slides Video

Access the full session

Session thumbnail
Biomarkers in acute coronary syndromes (2)

The Event

Event poster

ESC Congress 2025

29 August 2025 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Impact of stress hyperglycemia ratio on periprocedural myocardial infarction in patients with NSTEMI
thumbnail
Congress Presentation
Stress hyperglycemia ratio and long-term clinical outcome in patients with acute coronary syndrome
thumbnail
Congress Presentation
The combined and mediating prognostic impact of inflammation and stress hyperglycemia in diabetic and nondiabetic patients with acute coronary syndrome

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources